1 recruiting, 1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Receptors, Complement 3d: new trials by email Literature Review of Receptors, Complement 3d trials Research Report on Receptors, Complement 3d
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chidamide, Lenalidomide, and Rituximab in Newly Diagnosed Elderly/unFit DE-DLBCL Chidamide in combination with Lenalidomide and Rituximab (CR2) - Double Expressor DLBCL, ELDERLY PEOPLE | Phase 2 | Recruiting | The First Affiliated Hospital with Nanjing Medical University | 38 | 2024-03-11 | 2026-10-20 |
| Implication of CD35, CD21 and CD55 in Exudative Age-related Macular Degeneration cd 35, cd21, cd55 - Age-Related Macular Degeneration | Unknown | Rudolf Foundation Clinic | 120 | 2008-09-01 | 2010-08-03 |
Rudolf Foundation Clinic (1) · The First Affiliated Hospital with Nanjing Medical University (1)
Austria (1) · China (1)